View online issues

Click on the button for submission

As part of the submission process, authors are required to check off their submission’s compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the editor.
  • The submission file is in Microsoft Word, RTF, or Open Office document file format.
  • Where available, URLs for the references should be provided.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • The authors assure copyright of their article to the Institute of Hematology, Catholic University.
  • Authors have declared any possible conflict of interest.
  • Article Processing Charge
    Authors declare their availability to pay charges (600 Euros) for publication when the paper was accepted. Invited authors of review-articles are excluded from any payment. Authors from low-income countries can request to the Editor in Chief a reduction of the publication charges. The Article Processing Charges will have to be paid to the Publisher by Paypal or credit card at: https://mattiolihealth.com/shop/publication-fee-mediterranean-journal-of-hematology-and-infectious-diseases.
    The special price of 200 € is reserved to italian doctor in training, please see: https://mattiolihealth.com/shop/publication-fee-mediterranean-journal-of-hematology-and-infectious-diseases-special-price.
    The Editorial Board of the Mediterranean Journal of Hematology and Infectious Diseases is engaged in improving the quality of the papers published in our journal. So, with the agreement of the Publisher,  the possibility of publishing in MJHID without charge will be extended to the authors of the five papers which obtained the most citations which contributed to Impact Factor of the year throughout the two years following.

Click on the button to view Author Guidelines

MJHID publishes reviews and original articles related to the diagnosis, management, and research of hematologic and infectious diseases. The content of the MJHID is determined by the Editors. MJHID does not require any fee both for reviewing and online publication. MJHID, the Publisher, and the Editors of its publications assume no responsibility for the statements expressed by the contributors (and/or authors) of the articles. The manuscript submitted to the journal must not contain previously published material or material under consideration for publication elsewhere. Accepted manuscripts become the property of MJHID and may not be republished. All manuscripts will undergo peer review. A final report and a subsequent decision about publication will then be made by an MJHID Editor. If the Editor requires revision of the article, authors must send the correct version within three months, after three months, the item will be archived, unless the authors did not apply for an extension.

Responsibilities of the Authors

By submitting a manuscript for publication, each author acknowledges having made a substantial contribution in:

  • The conception and design of the study.
  • The analysis and interpretation of the results.
  • The writing of the paper.

and has approved the final submitted version of the manuscript. Each author thus also acknowledges responsibility for the integrity of the document, assures its originality, and guarantees that duplicate or redundant publications or submissions have not occurred. The Editors reserve the right to request the original data obtained in the investigation. Authors should declare any possible conflict of interest. Authors are responsible for all statements done in the text. Experiment on humans should be made according to Helsinki Declaration 2008, http://science.education.nih.gov/supplements/nih9/bioethics/guide/teacher/Mod5_Helsinki.pdf or after approval of the local ethical committee. Experiments on animals should respect the “Animal Welfare Act”, http://www.neavs.org/research/laws. Published Conflict-of-Interest Statement, Statements of Informed Consent and Human and Animal Right should be made according to the International Committee of Journal Medical Editors http://www.icmje.org/

Manuscript Submission

These instructions are based in part on recommendations in the Uniform Requirements for Manuscripts Submitted to Biomedical Journal [Ann. Intern. Med. 1997; 126: 36-47]. Variations from guidelines in this publication reflect the individual style of MJHID. The authors should submit the manuscript as a complete file. Download an electronic version of the text (as an MS WORD document), unlabeled and labelled images (as JPEG files). The manuscript should be typed in times new roman font, double-spaced throughout on one side of the A4/Letter paper with at least a 1.5 cm/ margin on all sides. Number all pages consecutively, beginning with the title page. Restrictions on page counts or the number of figures/videos are related to the type of submissions.

Organize the manuscript as follows: title page, abstract, introduction, material and methods, results, and a discussion including a conclusion, acknowledgements, references, figure legends, and tables. Keep acronyms and abbreviations to a minimum. When an abbreviation is used, define it at first mention and follow with the abbreviation in parentheses. All the manuscripts can be written both in American and British English. The inappropriateness of the language will not be considered sufficient reason to reject the article. However, it is recommended to check the English language by an expert.

Enago Inglese Editing Services

Enago offers Inglese language polishing services for scientific research papers for journal publication. Enago subject has expert editors (PhDs and Masters) with an average 19 years of editing experience. Other than Inglese editing, they offer all levels of publication to support authors, including revised rejected editing, journal selection, artwork editing, word count reduction and cover letter editing. An ISO 9001: 2008 certified company, Enago is very careful about the quality delivered to authors. Exclusive regional websites and services of Enago are listed below. Each of the websites Has localized payment options and invoices available on demand.

For Global researchers: Enago Global (http://www.enago.com). For Japanese researchers: Enago Japan. For Chinese researchers: Enago China. For Taiwanese researchers: Enago Taiwan. For Korean researchers: Enago Korea. For German researchers: Enago Germany. For Turkish researchers: Enago Turkey. For Portuguese researchers: Enago Brazil.

Categories of Submission

Review Articles

The review articles are solicited by the Editor in Chief or by the Guest Editors to authoritative investigators. Experts in the field, authors of publications in peer-reviewed journals also not-solicited can submit their manuscript; however, the authors are invited to communicate before the topic and to send a summary of their manuscript to obtain the approval of the Editor in Chief. The author(s) is free to design the paper. No particular format is required for these articles. Moreover, authors should take into consideration the suggestions of PRISMA Group, Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647. doi: 10.1136/bmj.g7647. http://www.bmj.com/content/349/bmj.g7647.long

However, they should have an informative, unstructured abstract of about 250 words; we suggest a limiting to 10-12 pages (5-6000 words +references), Mini reviews (<4000 words and <100 references) will also be considered. References, figures and legends follow the guidelines described below under Original Articles. The review articles are solicited by the Editors, but the journal may also consider reviews submitted on authors’ initiative, however, a pre-submission approval by the Editor in Chief should be obtained.

Original Articles

Title Page

The following information should appear: the title of the article, authors name, and last name, affiliations, grant support, and presentation in part or whole at any meeting. Please, identify the corresponding author and provide a full mailing address, phone and fax numbers, and e-mail address.

Abstract

Provide an abstract of not more than 250 words. It should consist of four paragraphs, labeled Background e Objectives, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the remarkable results, and what the authors conclude from the results. No references should be cited. Introduction. Include brief background information on what has been done in the past in this area and the importance of your investigation. End with a statement of the purpose or hypothesis of the study.

Material and Methods.

This section may be divided into subsections if it facilitates reading the paper. The research design, subjects, material used, and statistical methods should be included. Do not mix results and discussion into this section. Do not include manufacturers names unless the specific product is essential to the procedures performed, in which case the city and state or country of the manufacturer should also be given. Indicate that informed consent has been obtained from patients who participated in clinical investigations. In animal experimentation, acknowledge that ethical guidelines were followed. When appropriate, indicate that approval was obtained from the institution’s review board.

Results

This section may be divided into subsections if it facilitates reading the paper. All results based on methods must be included. If tables and graphic material will ease the understanding of the results, include them. Cite figures to illustrate the findings of the study.

Discussion

Start with limited background information and then discuss the results of the investigation in light of what has been published in the past, the limitations of your study, and potential directions for future research. Inappropriate place, cite figures and graphs. A conclusion should summarize the major findings of the study and their clinical usefulness.

Acknowledgments

Acknowledgments should appear on a separate page.

References

This section must be single spaced and begin on a separate sheet. References are numbered consecutively in the order in which they appear in the text. All references must be cited in the text, where numbers are enclosed in [square brackets] in line with the text (not superscript). Papers submitted but not yet accepted for publication should also be cited in the text. Inclusive page numbers (e.g., 491-492) must be provided for all references. Journal names should be abbreviated according to MeSH. All authors should be listed in references.

Style and punctuation of references

Journal article. [Reference number] Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P,Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL,Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. MicroRNA expression in cytogenetically normal acute myeloid leukemia.N Engl J Med. 2008;358:1919-28

Journal online article. [Reference number]Stoddart A, McNerney ME, Bartom E, Bergerson R, Young DJ, Qian Z, Wang J, Fernald AA, Davis EM, Larson RA, White KP, Le Beau MM. Genetic pathways leading to therapy-related myeloid neoplasms. Mediterr J Hematol Infect Dis. 2011;3:e2011019. Epub 2011 May 16.

Book. [Reference number] Noback CR, Demarest RJ. The Human Nervous System. 2nd Ed., New York, McGraw-Hill. 1975; 199-201.

Edited book. [Reference number] Wyngaarden JB. Principles of human genetics. In: Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine. 18th Ed., Philadelphia, W. B. Saunders Company. 1988; 146-152. URL (Web Page). [Reference number] Pantanowitz L, Früh K, Marconi S, Moses AV, Dezube BJ.

Pathology of rituximab-induced Kaposi sarcoma flare. http://www.biomedcentral.com/1472-6890/8/7 (published 23 July 2008).

Format: Author, if available. The title of the page as listed on the site. Address of page (date accessed).

Tables
Each table should be given on a separate page. Each table has a short, descriptive title. Tables are numbered in the order cited in the text. Abbreviations are defined as footnotes at the bottom of each table. Tables should not duplicate data given in the text or figures.

Figures and Legends
The complete sets of original figures must be submitted. Legends should be in the present tense (e.g., ‘Illustration shows …’). Subjects’ names must not appear on the figures. Labels should contrast well with the background. Images should be uniform in size and magnification. Illustrations should be free of all identifying information relative to the subject and institution. Line drawings should be professional in quality. Written permission for use of all previously published illustrations must be included with submission, and the source should be referenced in the legends. Written permission from any person recognizable in a photo is required. Legends must be double spaced, and figures are numbered in the order cited in the text. Label all pertinent findings.

Scientific Letters
Important new findings can be published in a format that fit a letter. Start the letter with a paragraph summarizing the rationale for the study and the major conclusions. The initial statement of this paragraph will be utilized as abstract and headlines. Scientific Letters have a maximum of 2000 words in the text (excluding title, affiliations, figures legends or references), a maximum of 3 tables and/or figures, and only 20 essential references. Letters will appear in the table of contents, have a DOI and be indexed in PubMed.

Case Reports

Clinical Cases can be published as Brief Reports. They will be taken into consideration only when significantly expand the field of general medical knowledge and/or contribute to extending the knowledge of the pathophysiology of the disease. The rarity of the case is not regarded as a criterium of priority.

Reports
Usually describe one to three patients or a single family. The text is limited to 2000 words, a maximum of 3 tables and figures (total), and up to 20 references. They begin with a brief summary of no more than 150 words

Educational Clinical Cases
Clinical Cases, when with a puzzling diagnosis at presentation,  and having a strong educational character, will be assigned to the section MJHID Educational Clinical Cases.  This section contains case studies of particular diagnostic difficulty and therapeutic interest. The diagnostic procedure should be represented step by step.  The iconography must be complete and original. The diagnostic tool should be updated or adapted to local conditions. Differential diagnosis should be an important point to consider.  Pages number and references are at the discretion of the authors (in general not more of 3000 words and 30 references). They begin with a brief summary of data of the patient at presentation. Please send to Editorial Office mjhid@mjhid.org a Presubmission Inquiry to obtain approval for Educational  Clinical Cases by the Editor in Chief. An example of an Educational Clinical Case can be viewed by clicking on http://www.mjhid.org/index.php/mjhid/article/view/2016.017

Letters to the Editor
Letters to the Editor may be used in primis to comment articles appeared in MJHID and to give an opinion or suggestions about topics recently treated in the MJHID. Letters should be no more than three pages and should be submitted with a brief title. A maximum of 8 references may be included. Letters are published at the discretion of the journal and are subject to editing. Case reports can be submitted as a letter to the editor only when referring to articles published in MJHID.

Books for Review
Publishers and authors who wish to have their titles considered for review should send review copies to. Unsolicited book reviews are not considered. The submission file is in Microsoft Word, RTF, or WordPerfect document file format.

Mediterranean Journal of Hematology and Infectious Diseases

Open access journal: www.mjhid.org


Editor in Chief

Prof. Giuseppe Leone, Editor in Chief Catholic University, Rome, Italy

Deputy Editor

Dr. Luciana Teofili, Italy

Coeditors

Dr. Luciana Teofili, Italy
Prof. Eligio Pizzigallo, “G. d’Annunzio” University of Chieti (IT), Italy
Prof. Francesco Lococo, Università di Roma TorVergata, Roma, Italy
Dr. Corrado Girmenia, Università “La Sapienza”. Roma, Italy
Prof. Livio Pagano, Università Cattolica, Italy
Prof. Giovanni de Gaetano, “John Paul II” Centre for High Technology Research, Italy
Prof. Luigi Maria Larocca, Catholic University, Rome, Italy

Editorial Board

Dr. Thomas V. Adamkiewicz, Morehouse School of Medicine, Atlanta, GA 30344, USA
Prof. Wassim Y Almawi, Faculty of Sciences El Manar University Tunis, Tunisia, Tunisia
Prof. Lodovico Balducci, Moffit Cancer Center, United States
Dr. Samir Ballas, Cardeza Foundation for Hematologic Research, Philadelphia.
Dr. Michele Bibas, Dipartimento clinico e di ricerca clinica, Ematologia – INMI “Lazzaro Spallanzani” IRCCS ROME, Italy
Prof. Maria Domenica Cappellini, University of Milan, Milan, Italy
Prof. Carmelo Carlo-Stella, Humanitas Research Hospital & University of Milano, Italy
Dr. Mammen Chandy, Tata Medical Center. Kolkata, India.
Dr. Raffaella Colombatti, Clinic of Pediatric Hematology-Oncology, Department of Pediatrics, Azienda Ospedaliera-Università di Padova, Padova, Italy., Italy
Prof. Giovanni Delogu, Institute of Microbiology, Catholic University, Rome, Italy., Italy
Ass. prof. Ilker Devrim, Dr.Behcet Uz Chıldrens Hospital, Turkey
Dr. Dimitar Efremov, International Center for Genetic Engineering & Biotechnology, Monterotondo Scalo, Italy
Prof. Mohssen Elalfy, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Egypt
Dr. Prof. Alison Freifeld, Alison Freifeld MD Professor, Internal Medicine Infectious Diseases Section University of Nebraska Medical Center Omaha, NE 68198-5400 402-559-8668
Prof. Gianluca Gaidano, University of Eastern Piedmont .Novara, Italy
Prof. Andrea Gallamini, Department of Research, Innovation and Statistics, A. Lacassagne Cancer Centre, Nice France, Italy
Dr. Kanjaksha Ghosh, National Institute Of Immunohaematology. ( ICMR )
Dr. Prof. Andreas H. Groll,, MD, Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, Children’s University Hospital, Albert-Schweitzer-Campus 1, Building A1, Münster 48149, Germany. Tel.: +49 251 834 7742. Fax: +49 251 834 7828. E-mail:, Germany
Prof. Olivier Hermine, Hopital Necker, Paris, France
Prof. Hee-Je Kim, Department of Hematology, Cancer Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Korea, Republic of
Dr. Stefan Hohaus, Catholic University, Italy
Prof. Sanaa Kamal, Ain Shams University/Tufts Medical School, United States
Prof. Giorgio La Nasa, Università di Cagliari., Italy
Prof. Richard A. Larson, University of Chicago, United States
Dr. Antonio Maria Leone, Università Cattolica del Sacro Cuore Roma, Italy
Prof. Lucio Luzzatto, Istituto Toscano Tumori, Firenze, Italy
Dr. Maurizio Martini, Università Cattolica del Sacro Cuore, Roma, Italy
Dr. Annarita Migliaccio, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
Dr. Janos Minarovits, Microbiological Research Group, National Center for Epidemiology, Hungary
Prof. Moshe Mittelman, Department of Medicine, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel, Israel, Israel
Prof. Raffaella Origa, Clinica Pediatrica 2°, Dipartimento di Sanità Pubblica, Medicina Clinica e Molecolare, Università di Cagliari, Ospedale Regionale per le Microcitemie, ASL 8 Cagliari, Italy
Prof. Eliezer A. Rachmilewitz, Medicine and Pediatrics, Presbyterian Hospital, New York Cornell University, New York, NY, USA
Prof Josep-Maria Ribera, Clinical Hematology Department ICO-Hospital Germans Trias i Pujol Jose Carreras Research Institute Badalona, Spain, Spain
Dr. Deborah Rund, Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, Israel
Prof. Miguel A. Sanz, Hospital Universitario La Fe Servicio de Hematología Valencia, Spain, Spain
Prof. Simona Sica, Università Cattolica del Sacro Cuore. Roma, Italy
Dr George Vassilopoulos, University of Thessaly Medical School, Greece
Prof. Adriano Venditti, Università Roma Torvergata, Italy
Dr. Lorenzo Zammarchi, Infectious Diseases Unit, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Italy

Past and Present Guest Editors

Prof Sergio Amadori, Università Torvergata, Roma, Italy
Prof. Luca Arcaini, Luca Arcaini, MD, Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy. E-mail: luca.arcaini@unipv.it
Prof. Giuseppe Avvisati, Capus Biomedico, Italy
Prof. Michele Baccarani
Prof. Lodovico Balducci, Moffit Cancer Center, United States
Prof. Renato Bassan
Prof. Maria Domenica Cappellini, University of Milan, Milan, Italy
Prof. Giancarlo Castaman, Italy
Prof. Francesco Castelli, University of Brescia Clinic of Infectious Diseases
Prof. Roberto Cauda, Istituto Clinica Malattie Infettive.Università Cattolica.Roma, Italy
Dr. Chiara Cerletti
Prof. Giovanni de Gaetano, “John Paul II” Centre for High Technology Research, Italy
Prof. Valerio De Stefano, Università Cattolica del Sacro Cuore
Dr. Dimitar Efremov, International Center for Genetic Engineering & Biotechnology, Monterotondo Scalo, Italy
Prof. Andrea Gallamini, Department of Research, Innovation and Statistics, A. Lacassagne Cancer Centre, Nice France, Italy
Prof. Augusto Federici, Università di Milano, Italy
Prof. Antonio Gasbarrini, Università Cattolica
Prof. Luigi Maria Larocca, Catholic University, Rome, Italy
Prof. Richard A. Larson, University of Chicago, United States
Prof. Luca Laurenti, pol. a gemelli, Italy
Prof. Mario Luppi, Dip.Oncoematologia Università di Modena
Prof. Francesco Lococo, Università di Roma TorVergata, Roma, Italy
Prof. Alberto Matteelli, Institute of Infectious and Tropical Diseases, University of Brescia, 1-25123 Brescia, Italy. Electronic address:, Italy
Prof. Cristina Mecucci, University of Perugia, Italy
Prof Giovanna Meloni, Italy
Prof. Raffaella Origa, Clinica Pediatrica 2°, Dipartimento di Sanità Pubblica, Medicina Clinica e Molecolare, Università di Cagliari, Ospedale Regionale per le Microcitemie, ASL 8 Cagliari, Italy
Prof. Livio Pagano, Università Cattolica, Italy
Prof. Fabrizio Pane, Departments of Biochemistry and Medical Biotechnology, Federico II University Medical School, Naples, Italy., Israel
Dr. Maria Teresa Petrucci, Sapienza University of Rome, Italy
Prof. Eligio Pizzigallo, “G. d’Annunzio” University of Chieti (IT), Italy
Prof. Alessandro Rambaldi, University of Milan, Ospedale Papa Giovanni XXIII, Bergamo, Italy
Dr. Francesco Rodeghiero
Prof. Miguel A. Sanz, Hospital Universitario La Fe Servicio de Hematología Valencia, Spain, Spain
Prof. Corrado Tarella, Department of Biotechnology and Life Sciences, University of Torino, Torino, Italy, Hematology and Cell Therapy Division, Mauriziano Hospital, Torino, Italy
Prof. Adriano Venditti, Università Roma Torvergata, Italy
Dr. Giuseppe Visani, Ospedale S. Salvatore, Pesaro. Italy
Prof. Maria Teresa Voso, Università di Roma Torvergata, Italy

 


The Journal publishes original articles and topical reviews concerning both clinical hematology and infectious diseases. A particular attention will be deserved to original articles focusing on the relationship between blood and infectious diseases

Language: English
Frequency: annual, online-only
Format: 20 x 27 cm
eISSN: 2035-3006

Mediterranean Journal of Hematology and Infectious Diseases is indexed in: Science Citation Index Expanded, Journal Citation Reports/InCites, PubMed/Medline, PubMed Central, Scopus (Elsevier).
First 2017 official Impact Factor: 1.183

Open access journal: www.mjhid.org

 


ULTIME PUBBLICAZIONI

Giugno 14, 2019

Agevolazioni fee di pubblicazione – Mediterranean Journal of Hematology and Infectious Diseases

Per stimolare la partecipazione dei giovani specializzandi in Ematologia e Infettivologia è stata approvata dal Comitato Editoriale della rivista una ridotta tariffa di pubblicazione per tutti […]
Maggio 27, 2019

Online i nuovi articoli di Mediterranean Journal of Hematology and Infectious Diseases

Sono online i nuovi articoli della rivista Mediterranean Journal of Hematology and Infectious Diseases